Fortuna Health vs Revvity

Side-by-side comparison of AI visibility scores, market position, and capabilities

Revvity leads in AI visibility (94 vs 20)
Fortuna Health logo

Fortuna Health

EmergingHealthcare

General

NYC YC "TurboTax for Medicaid" at $22M total ($18M a16z Series A Jul 2025) with AI + live navigators reducing member churn 15% addressing $50B administrative waste; 12-person team competing with Maximus for Medicaid enrollment technology.

AI VisibilityBeta
Overall Score
D20
Category Rank
#491 of 1158
AI Consensus
47%
Trend
up
Per Platform
ChatGPT
14
Perplexity
15
Gemini
31

About

Fortuna Health is a New York City-based healthcare technology company — backed by Y Combinator with $22 million in total funding including an $18 million Series A in July 2025 led by Andreessen Horowitz (a16z) with BoxGroup, and a $4 million seed in November 2023 from YC, BoxGroup, and angel investors including founders of Zocdoc, PillPack, and Cityblock Health — providing Medicaid health plans, providers, and state governments with an AI-powered Medicaid navigation platform that pairs AI automation with live human navigators to guide beneficiaries through enrollment, coverage maintenance, and renewal workflows, reducing member churn by 15% and addressing the $50 billion in administrative waste that the US Medicaid system generates annually. Founded in 2023 by Cydney Kim, Nikita Singareddy, and Ben Wesner, Fortuna Health operates with a 12-person team and has been described as "TurboTax for Medicaid."

Full profile
Revvity logo

Revvity

LeaderHealthcare Tech

Life Science Tools & Diagnostics

Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.

AI VisibilityBeta
Overall Score
A94
Category Rank
#1 of 1
AI Consensus
72%
Trend
up
Per Platform
ChatGPT
92
Perplexity
99
Gemini
96

About

Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.

Full profile

AI Visibility Head-to-Head

20
Overall Score
94
#491
Category Rank
#1
47
AI Consensus
72
up
Trend
up
14
ChatGPT
92
15
Perplexity
99
31
Gemini
96
30
Claude
89
14
Grok
88

Key Details

Category
General
Life Science Tools & Diagnostics
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Revvity
Life Science Tools & Diagnostics

Integrations

Only Revvity
Revvity is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.